HC Surgical Specialists Limited (SGX:1B1)
Singapore · Delayed Price · Currency is SGD 0.3500
0.00 (0.00%)
At close: Sep 7, 2026
HC Surgical Specialists Income Statement
Financials in millions SGD. Fiscal year is June - May.
Millions SGD. Fiscal year is Jun - May.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Operating Revenue | 19.38 | 19.11 | 18.81 | 19.08 | 19.31 |
Other Revenue | 0.35 | 0.19 | 0.16 | 0.1 | 0.11 |
| 19.73 | 19.3 | 18.97 | 19.18 | 19.42 | |
Revenue Growth | 2.22% | 1.77% | -1.10% | -1.24% | -17.25% |
Cost of Revenue | 11.16 | 10.38 | 9.89 | 9.28 | 9.48 |
Gross Profit | 8.57 | 8.92 | 9.08 | 9.9 | 9.94 |
Selling, General & Admin | 0.03 | 0.03 | 0.02 | 0.02 | 0.06 |
Other Operating Expenses | 1.59 | 1.53 | 1.59 | 2.26 | 1.49 |
Operating Expenses | 3.63 | 3.49 | 3.65 | 4.03 | 3.22 |
Operating Income | 4.94 | 5.43 | 5.43 | 5.87 | 6.72 |
Interest Expense | -0.11 | -0.26 | -0.5 | -0.64 | -0.47 |
Interest & Investment Income | 0.52 | 0.54 | 0.77 | 0.82 | 0.82 |
Earnings From Equity Investments | 0.96 | 0.78 | -0.09 | - | - |
Other Non Operating Income (Expenses) | -0.36 | 1.84 | -0.45 | 0.36 | 0.53 |
EBT Excluding Unusual Items | 5.95 | 8.34 | 5.16 | 6.42 | 7.59 |
Merger & Restructuring Charges | -0.01 | -0.02 | - | - | - |
Impairment of Goodwill | - | - | - | -0.68 | -0.75 |
Gain (Loss) on Sale of Investments | 1.65 | 0.49 | -0.06 | -1.62 | 0.99 |
Gain (Loss) on Sale of Assets | - | - | - | 0 | -0.02 |
Asset Writedown | 0.05 | -0 | -0.16 | -0.13 | -0.07 |
Other Unusual Items | - | - | 0.12 | 0.06 | -0.01 |
Pretax Income | 7.64 | 8.8 | 5.06 | 4.05 | 7.75 |
Income Tax Expense | 0.45 | 0.02 | 1.12 | 1.07 | 0.94 |
Earnings From Continuing Operations | 7.19 | 8.78 | 3.94 | 2.99 | 6.8 |
Minority Interest in Earnings | -0.21 | -0.34 | -0.09 | -0.07 | -0.42 |
Net Income | 6.98 | 8.44 | 3.85 | 2.92 | 6.38 |
Net Income to Common | 6.98 | 8.44 | 3.85 | 2.92 | 6.38 |
Net Income Growth | -17.24% | 119.42% | 31.76% | -54.25% | -20.25% |
Shares Outstanding (Basic) | 153 | 154 | 152 | 149 | 149 |
Shares Outstanding (Diluted) | 153 | 154 | 152 | 149 | 149 |
Shares Change | -0.22% | 0.94% | 2.28% | - | -0.72% |
EPS (Basic) | 0.05 | 0.05 | 0.03 | 0.02 | 0.04 |
EPS (Diluted) | 0.05 | 0.05 | 0.03 | 0.02 | 0.04 |
EPS Growth | -17.12% | 117.39% | 28.82% | -54.25% | -19.68% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Free Cash Flow | 7.15 | 6.75 | 6.23 | 6.51 | 6.84 |
Free Cash Flow Per Share | 0.05 | 0.04 | 0.04 | 0.04 | 0.05 |
Dividend Per Share | 0.021 | 0.020 | 0.014 | 0.020 | 0.026 |
Dividend Growth | 5.05% | 41.43% | -30.00% | -23.08% | -35.00% |
Gross Margin | 43.43% | 46.23% | 47.87% | 51.63% | 51.18% |
Operating Margin | 25.03% | 28.13% | 28.62% | 30.62% | 34.59% |
Profit Margin | 35.40% | 43.72% | 20.28% | 15.22% | 32.85% |
Free Cash Flow Margin | 36.23% | 34.95% | 32.85% | 33.95% | 35.20% |
EBITDA | 5.37 | 5.87 | 5.92 | 6.31 | 7.22 |
EBITDA Margin | 27.20% | 30.40% | 31.24% | 32.91% | 37.20% |
D&A For EBITDA | 0.43 | 0.44 | 0.5 | 0.44 | 0.51 |
EBIT | 4.94 | 5.43 | 5.43 | 5.87 | 6.72 |
EBIT Margin | 25.03% | 28.13% | 28.62% | 30.62% | 34.59% |
Effective Tax Rate | 5.83% | 0.24% | 22.17% | 26.35% | 12.19% |